Publication

2010 - Springer Verlag, Heidelberg, Germany

Language

English

Word Count

76,500 words, Guess

Page Count

306 pages

Identifiers

  • Internet Archivephosphoinositide0346unse
  • ISBN-10364213663X
  • ISBN-103642136621
  • ISBN-139783642136634
  • ISBN-139783642136627
and 5 more
  • OCLC Control Number682910817
  • OCLC Control Number646114684
  • Better World Books9783642136627
  • Better World Books9783642136634
  • Open LibraryOL28034066M

Classifications

  • DDC612.015
  • LCCQP752.P52
  • LCCRC261-271QP34-38QH50
and 3 more
  • LCCRC261-271
  • LCCQP752
  • LCCQR1 .E62 v.346

Description

From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in progress. Here the authors give a brief overview of some key discoveries in the PI3K area and their impact, and include thoughts on the current state of the field, and where it could go from here.

Subjects

Series Statement

  • Current topics in microbiology and immunology -- v. 346

Links

Other Editions

  • Phosphoinositide 3-kinase in health and diseaseSpringer Verlag2010-01-01

Reader Reviews

No reviews yet for this book.

Be the first to share your thoughts!